In gene panel sequencing for breast cancer predisposition, CHEK2 is consistently found to have a high number of pathogenic variants, usually only surpassed by the number of pathogenic variants identified in BRCA1 and BRCA2 in most settings not involving selection by breast cancer subtype [21,22]. The gene discussed is BRCA2; the disease is breast carcinoma.